EGFR and non-small cell lung carcinoma: Our findings suggest a high frequency of occult EGFR mutations in NSCLC patients, particularly in male smokers and female non-smokers, highlighting the importance of routine evaluation for EGFR mutations to enable targeted therapeutic benefits.